Article Information
History
- December 21, 2023.
Article Versions
- Version 1 (February 7, 2023 - 17:18).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available for use under a CC0 license.
Author Information
- Christine Tedijanto1,
- Solomon Aragie2,
- Sarah Gwyn3,
- Dionna M. Wittberg1,
- Taye Zeru4,
- Zerihun Tadesse2,
- Ambahun Chernet2,
- Isabel J.B. Thompson1,
- Scott D. Nash5,
- Thomas M. Lietman1,6,7,
- Diana L. Martin3,
- Jeremy D. Keenan1,6 and
- Benjamin F. Arnold1,6,*
- 1Francis I. Proctor Foundation, University of California San Francisco, San Francisco, CA, USA
- 2The Carter Center Ethiopia, Addis Ababa, Ethiopia
- 3Division of Parasitic Diseases and Malaria, Centers for Disease Control and Prevention, Atlanta, GA, USA
- 4Amhara Public Health Institute, Bahir Dar, Ethiopia
- 5The Carter Center, Atlanta, GA, USA
- 6Department of Ophthalmology, University of California San Francisco, San Francisco, CA, USA
- 7Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, CA, USA
- ↵*Corresponding author:
Benjamin F. Arnold, PhD, Associate Professor, Francis I. Proctor Foundation, University of California, San Francisco, ben.arnold{at}ucsf.edu
Posted December 21, 2023.
Seroreversion to Chlamydia trachomatis Pgp3 antigen among children in a hyperendemic region of Amhara, Ethiopia
